Evidence map›Paper›PMID 34298582›Full record

ArticleCPT: pharmacometrics & systems pharmacology2021

CPT: Pharmacometrics & Systems Pharmacology - Inception, Maturation, and Future Vision.

Karen Rowland Yeo, Stefanie Hennig, Sriram Krishnaswami, Natasha Strydom, Vivaswath S Ayyar, Jonathan French, Vikram Sinha, Eric Sobie, Ping Zhao, Lena E Friberg and 1 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Quantitative approaches to drug safety: The 2022 PSP special issue.CPT: pharmacometrics & systems pharmacology · 2022
    Article
  4. Review
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Karen Rowland YeoCertara UK Ltd (Simcyp Division), Sheffield, UK.
Stefanie HennigCertara, Inc, Princeton, NJ, USA.ORCID 0000-0001-5972-3711
Sriram KrishnaswamiPfizer, Groton, CT, USA.
Natasha StrydomDepartment of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California, San Francisco, CA, USA.ORCID 0000-0002-0929-0783
Vivaswath S AyyarJanssen Research & Development, LLC, Spring House, PA, USA.
Jonathan FrenchMetrum Research Group, Tariffville, CT, USA.ORCID 0000-0001-9649-169X
Vikram SinhaTakeda, Cambridge, MA, USA.
Eric SobieDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ping ZhaoBill & Melinda Gates Foundation, Seattle, WA, USA.
Lena E FribergDepartment of Pharmacy, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-2979-679X
France MentréIAME, INSERM, Université de Paris, Paris, France.ORCID 0000-0002-7045-1275

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Network PharmacologyComputational BiologyHumansModels, BiologicalPeriodicals as Topic

Identifiers

PMID34298582
PMCPMC8302238

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.